(PharmaNewsWire.Com, August 12, 2017 ) This report provides an important expert quantitative analysis on the contract dose manufacturing industry. PharmSource is the most definitive, “PharmSource Contract Dose Manufacturing Industry” trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
Founded on the industrys most comprehensive database of the dose CMO industry (PharmSources Strategic Advantage Database of Contract Service Providers) this analysis is driven by our proprietary model of the dose manufacturing industry, which is continuously updated and refined. The model and assumptions are fully explained so readers can understand how the analysis and conclusions have been established.
This 29-page report includes an Executive Summary and chapters on Industry Size and Structure, Industry Size and Growth, CMO Market Shares and concludes with a chapter on The Outlook for the Dose CMO Industry, which provides further analysis and assesses the reports implications for the dose CMO industry. In addition, it includes an appendix on methodology.
Scope
- This report characterizes the contract dose manufacturing industry along a number of quantitative dimensions, including number and type of participants, market size and market shares of the top CMOs, and provides PharmSources expert outlook for the industry. - The contract dose manufacturing universe, for purposes of this report, includes companies that actively promote themselves as contract manufacturers (CMOs) that produce a clients formulations for pharmaceuticals supplied to the highly regulated markets in North America, Europe and Japan.
- The report defines the contract dose manufacturing universe as including 282 companies headquartered primarily in North America, Europe, Japan and India.
Reasons to buy
The expertise and skilled analysis in this 29-page report gives important insight you wont find in any other source. This report is required reading for - - CMO executives and strategic decision-makers: youll find this report an indispensable resource for understanding the industry and a critical input for strategic planning efforts. - Sourcing and procurement executives in bio/pharmaceutical companies: youll find the report a critical resource for understanding crucial components of the supply base that will provide insights for supplier selection and management. - Private equity investors: youll get a deeper understanding of the market and important insight for identifying potential investment targets.
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
